Chronic Adaptive versus Conventional Deep Brain Stimulation in Patients with Parkinson's Disease: A Randomized Crossover Trial with Exploratory Analysis of Baseline-Dependent Response Patterns

- Posted by system in English

Analysis of the Significance, Importance, Timeliness, and Relevance of the Topic

The topic of adaptive deep brain stimulation (aDBS) versus conventional DBS (cDBS) in Parkinson's disease patients is significant, important, and timely. Parkinson's disease is a chronic and debilitating neurodegenerative disorder affecting millions worldwide, and deep brain stimulation (DBS) is a established treatment option for motor symptoms. However, the current standard of care, cDBS, has limitations, particularly in its reliance on fixed stimulation parameters. The potential of aDBS to modulate stimulation based on real-time biomarkers offers a promising approach to improving treatment outcomes.

Breakdown of the Text and Relationships between Items

  1. Background: The text sets the context for the study, highlighting the limitations of cDBS and the potential of aDBS to offer advantages. It also notes the inconclusive evidence on aDBS efficacy under chronic stimulation.
  2. Objective: The objective of the study is clearly stated, aiming to compare the efficacy of aDBS versus cDBS under chronic stimulation in Parkinson's disease patients.
  3. Methods: The text describes the study design, including the double-blind, randomized crossover trial, patient selection, and stimulation protocols. The use of a dual-threshold algorithm to adjust amplitude in response to subthalamic beta-band LFP power is a key aspect of aDBS.
  4. Results: The results show no statistically significant differences between aDBS and cDBS across primary outcomes. However, exploratory analyses reveal heterogeneous directional effects, with some outcomes favoring aDBS and others favoring cDBS.
  5. Conclusions: The study concludes that aDBS and cDBS show comparable efficacy across clinical outcomes under chronic stimulation with optimized medication. The findings suggest that baseline clinical characteristics of patients may shape the results of aDBS, warranting larger trials to identify patient subgroups who may benefit from each stimulation approach.

Usefulness of the Text for Disease Management and Drug Discovery

While the study does not provide original information beyond the obvious, it contributes to the growing body of evidence on aDBS efficacy. The findings have implications for the management of Parkinson's disease, suggesting that aDBS may be a viable treatment option for certain patient subgroups. However, the study's limitations, including the small sample size and short trial duration, highlight the need for further research to fully understand the potential of aDBS.

Originality of Information

The study's findings are consistent with existing literature on aDBS, and the results are not surprising given the small sample size and exploratory nature of the study. However, the study's methodology and analysis are rigorous, and the conclusions are well-supported by the data. The text does not provide any new or groundbreaking information but rather contributes to the cumulative knowledge on aDBS efficacy.

Comparison with the State of the Art

The study's findings are consistent with existing studies on aDBS efficacy, which have reported mixed results. However, the study's use of advanced analysis techniques, such as mixed-effects analysis of covariance, and its focus on exploratory analyses to examine treatment-by-baseline interactions are novel aspects of the study. The study's findings highlight the need for larger trials to identify patient subgroups who may benefit from each stimulation approach, which is a key area of ongoing research in the field.

In conclusion, the text provides a well-structured and informative analysis of the efficacy of aDBS versus cDBS in Parkinson's disease patients. While the study does not provide original information beyond the obvious, it contributes to the growing body of evidence on aDBS efficacy and has implications for the management of Parkinson's disease.

Read the original article on medRxiv

Patient-Level Stroke Outcomes Following Linkage of a Statewide Stroke Registry to Administrative Claims Data

- Posted by system in English

BackgroundCollection of patient-level outcomes data following hospital discharge is challenging for stroke registries. Data linkage to administrative claims data is a potential solution to obtain outcomes data. We aimed to generate data on 30-day, 90-day and 1-year outcome events following hospitalization for stroke using linked data in Michigan.

MethodsWe probabilistically linked clinical data from a 5-year cohort (2016-2020) of all index acute stroke discharges (ICD-10 I61-I63) from 31 hospitals participating in Michigans Acute Stroke program (MiSP) to a representative statewide multi-payer claims database. We used the linked data to generate data on 30-day, 90-day, and 1-year event rates including hospital readmissions, stroke recurrence, post-acute care services (i.e., facility-based rehabilitation and home health), and out-patient visits. Mortality data was only available for Medicare fee-for-service beneficiaries. Outcomes were stratified by age, race, stroke type, and stroke severity.

ResultsOf the 46,330 MiSP stroke discharges, 23,918 (51.6%) were linked to the claims database. Readmission and stroke recurrence rates were 14.1% and 3.3%, respectively, at 30 days, increasing to 42.2% and 8.3% at one year. By 30 days about a quarter of subjects had used facility-based rehab and another quarter had used home health; home health utilization increased to 44.7% by one year. At all time points Black patients had significantly higher readmission rates compared to whites, but higher stroke recurrence rates were only observed at the 1-year mark. At 30 days, utilization of post-acute care services did not differ by race, but utilization rates were significantly higher in Blacks at 90 days and one year. In contrast utilization of outpatient services was significantly higher among White patients at all time points.

ConclusionsLinkage between acute stroke registry and claims data provides an important source of surveillance data for stroke outcomes up to 1-year post discharge. This data allows for real-time monitoring of healthcare outcomes and potentially leads to interventions to improve stroke care.

Read the original article on medRxiv

Research on Epilepsy Detection and Recognition Based on the Combination of Time Frequency Transform and Deep Learning Model

- Posted by system in English

Analysis of the Text: Significance, Importance, Timeliness, and Relevance

The text discusses the improvement of epileptic electroencephalogram (EEG) signal detection using combined techniques of signal processing and machine learning. This topic is significant because accurate detection of EEG signals can help diagnose and manage epilepsy more effectively.

Significance: The accurate detection of EEG signals is crucial for diagnosing and managing epilepsy, a neurological disorder affecting millions of people worldwide. Incorrect or delayed diagnosis can lead to unnecessary treatments and complications.

Importance: The study's findings can contribute to the development of more efficient and accurate diagnostic tools, ultimately improving patient outcomes.

Timeliness: With the increasing availability of EEG technology, there is a growing need for more sophisticated analysis tools. This study's focus on combining signal processing and machine learning techniques to improve EEG signal detection is timely and relevant.

Relevance: The study's findings have implications for epilepsy research, clinical practice, and potential applications in other neurological disorders.

Analysis of the Text: Components and Relationships

  • Continuous Wavelet Transform (CWT): A signal processing technique used to analyze non-stationary signals. The CWT is used in combination with other methods to improve EEG signal detection.
  • Short-Time Fourier Transform (STFT): Another signal processing technique used to analyze signals with time-varying characteristics. The STFT is combined with the CWT and neural networks to improve signal detection.
  • Neural Network Models: Three different models (EEGNet, AlexNet, and Shallow ConvNet) are used to analyze EEG signals. Each model is optimized with different techniques to improve its performance.
  • Innovative Designs: The study introduces new designs, such as Focal Loss, dynamic data augmentation, and an early stopping mechanism, to enhance model robustness.
  • Results: The study's results show that the combination of CWT and Shallow ConvNet achieved a 100% recall rate with 99.14% accuracy, while the CWT+EEGNet combination achieved 100% accuracy.

Usefulness for Disease Management or Drug Discovery:

The study's findings can contribute to the development of more accurate diagnostic tools for epilepsy, which can lead to better disease management and treatment outcomes. The combination of signal processing and machine learning techniques used in this study can be applied to other neurological disorders, potentially leading to new insights and discoveries.

Original Information Beyond the Obvious:

While the study's findings are not revolutionary, they do provide new insights into the combination of signal processing and machine learning techniques for EEG signal detection. The innovative designs introduced in this study, such as Focal Loss and dynamic data augmentation, can be applied to other machine learning applications beyond EEG signal detection.

Comparative Analysis with State-of-the-Art:

The study builds upon existing techniques and introduces new designs to improve model robustness. The results demonstrate the effectiveness of combining precise time-frequency features with optimized models, which provides support for clinical practice. The study's findings can be compared with other studies that have used similar techniques, such as machine learning-based EEG signal analysis.

In conclusion, the text provides a clear analysis of the techniques used to improve EEG signal detection for epileptic patients. The study's findings are significant, timely, and relevant, and can contribute to the development of more accurate diagnostic tools for epilepsy and other neurological disorders.

Read the original article on medRxiv


Please, help us continue to provide valuable information:

Useful Links

Quick Links

Get in Touch

Le Duzic, Hameau de la Goduçais, Le Minihic sur Rance, 35870, France

Contact the author